Overview

Genome Editing Market is estimated to value over USD 7.5 billion by 2027 end during the forecast period 2020 to 2027.

The rising support from governments for conducting researches on genome editing which has resulted in the growth of production of genetically modified plants is the primary factor responsible for the growth of the market. Furthermore, the market growth os based on factors such as growing prevalence of chronic diseases like cancer.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Genome Editing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Genome Editing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Genome Editing Market:

• Thermo Fisher Scientific
• Merck
• Horizon Discovery Group
• Genscript
• Sangamo Biosciences
• Integrated Dna Technologies
• Lonza
• New England Biolabs
• Origene Technologies
• Transposagen Biopharmaceuticals
• Editas Medicine
• Crispr Therapeutics

(Note: The list of the major players will be updated with the latest market scenario and trends)

Genome Editing Market Segmentation:

By Technology

• CRISPR
• Talen
• ZFN
• Antisense
• Other Technologies

By Application

• Cell Line Engineering
• Genetic Engineering
• Animal Genetic Engineering
• Plant Genetic Engineering
• Other Applications

By End User

• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutions
• Contract Research Organization

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Genome Editing Market By Technology, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
       1.4 Currency 
       1.5 Limitations 
       1.6 Stakeholders 

 2.  Research Methodology 
       2.1 Research Data 
            2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
            2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
       2.2 Market Size Estimation 
       2.3 Market Breakdown and Data Triangulation 
       2.4 Assumptions for the Study  

3. Executive Summary
       3.1 Market Outlook
       3.2 Segment Outlook
       3.3 Competitive Insights

4. Global Genome Editing Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances

5. Market Overview
       5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Genome Editing Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Genome Editing Market Analysis Tools
       6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
       6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
       6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
       6.4. Market Entry Strategies
       6.5. Case Studies

7. Global Genome Editing Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
       7.1. CRISPR
       7.2. Talen
       7.3. ZFN
       7.4. Antisense
       7.5. Other Technologies 

8. Global Genome Editing Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
       8.1. Cell Line Engineering
       8.2. Genetic Engineering
            8.2.1. Animal Genetic Engineering
            8.2.2. Plant Genetic Engineering
       8.5. Other Applications

9. Global Genome Editing Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
       9.1. Biotechnology & Pharmaceutical Companies
       9.2. Academic & Research Institutions
       9.3. Contract Research Organization

10.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       10.1. Introduction
       10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            10.2.1. U.S.A
            10.2.2. Canada
            10.2.3. Mexico
       10.3. Market Size (USD Million) Forecast for North America 2020-2027

11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       11.1. Introduction
       11.2. Regional Market Trends
       11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            11.3.1. Brazil
            11.3.2. Venezuela
            11.3.3. Argentina
            11.3.4. Rest of Latin America
       11.4. Market Size (USD Million) Forecast for Latin America 2020-2027

12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       12.1. Introduction
       12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            12.2.1. Germany
            12.2.2. U.K
            12.2.3. France
            12.2.4. Italy
            12.2.5. Spain
            12.2.6. Russia
            12.2.7. Poland
            12.2.8. Switzerland
            12.2.9. Rest of Western Europe

13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       13.1. Introduction
       13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             13.2.1. Japan
             13.2.2. China
             13.2.3. Singapore
             13.2.4. India
             13.2.5. Australia and New Zealand
             13.2.6. ASEAN
             13.2.7. South Korea
             13.2.8. Rest of Asia Pacific
       13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027

14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       14.1. Introduction
       14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             14.2.1. Saudi Arabia
             14.2.2. UAE
             14.2.3. South Africa
             14.2.4. Egypt
       14.3. Market Size (USD Million) Forecast for MEA 2020-2027

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
       15.1. Thermo Fisher Scientific
                15.1.1. Company Overview
                15.1.2. Product Portfolio
                15.1.3. SWOT Analysis
                15.1.4. Financial Overview
                15.1.5. Strategic Overview
       15.2. Merck
               15.2.1. Company Overview
                15.2.2. Product Portfolio
                15.2.3. SWOT Analysis
                15.2.4. Financial Overview
                15.2.5. Strategic Overview
       15.3. Horizon Discovery Group
                15.3.1. Company Overview
                15.3.2. Product Portfolio
                15.3.3. SWOT Analysis
                15.3.4. Financial Overview
                15.3.5. Strategic Overview
       15.4. Genscript
                15.4.1. Company Overview
                15.4.2. Product Portfolio
                15.4.3. SWOT Analysis
                15.4.4. Financial Overview
                15.4.5. Strategic Overview
       15.5. Sangamo Biosciences
                15.5.1. Company Overview
                15.5.2. Product Portfolio
                15.5.3. SWOT Analysis
                15.5.4. Financial Overview
                15.5.5. Strategic Overview
       15.6. Integrated Dna Technologies
                15.6.1. Company Overview
                15.6.2. Product Portfolio
                15.6.3. SWOT Analysis
                15.6.4. Financial Overview
                15.6.5. Strategic Overview
       15.7. Lonza
                15.7.1. Company Overview
                15.7.2. Product Portfolio
                15.7.3. SWOT Analysis
                15.7.4. Financial Overview
                15.7.5. Strategic Overview
       15.8. New England Biolabs
                15.8.1. Company Overview
                15.8.2. Product Portfolio
                15.8.3. SWOT Analysis
                15.8.4. Financial Overview
                15.8.5. Strategic Overview
       15.9. Origene Technologies
                15.9.1. Company Overview
                15.9.2. Product Portfolio
                15.9.3. SWOT Analysis
                15.9.4. Financial Overview
                15.9.5. Strategic Overview
       15.10. Transposagen Biopharmaceuticals
                15.10.1. Company Overview
                15.10.2. Product Portfolio
                15.10.3. SWOT Analysis
                15.10.4. Financial Overview
                15.10.5. Strategic Overview
       15.11. Editas Medicine
                15.11.1. Company Overview
                15.11.2. Product Portfolio
                15.11.3. SWOT Analysis
                15.11.4. Financial Overview
                15.11.5. Strategic Overview
       15.12. Crispr Therapeutics
                15.12.1. Company Overview
                15.12.2. Product Portfolio
                15.12.3. SWOT Analysis
                15.12.4. Financial Overview
                15.12.5. Strategic Overview

16. FutureWise SME key takeaway points for Client

Tables

Figures